SOUTHWEST EYE INSTITUTE, INC. – Trademark Portfolio
Entity Type: 03
SOUTHWEST EYE INSTITUTE, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CLEARSIGHT LASIK and CLEARSIGHT CENTER. The owner is based in OKLAHOMA CITY, OK.
7101 NW EXPRESSWAY, SUITE 335
OKLAHOMA CITY, OK 73132
Showing of trademarks Trademarks
Trademark Classifications
SOUTHWEST EYE INSTITUTE, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does SOUTHWEST EYE INSTITUTE, INC. have?
SOUTHWEST EYE INSTITUTE, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does SOUTHWEST EYE INSTITUTE, INC. file in?
SOUTHWEST EYE INSTITUTE, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SOUTHWEST EYE INSTITUTE, INC.'s most well-known trademarks?
SOUTHWEST EYE INSTITUTE, INC.'s registered trademark portfolio includes well-known marks such as CLEARSIGHT LASIK and CLEARSIGHT CENTER. These are among 2 currently registered trademarks in the portfolio.
What is SOUTHWEST EYE INSTITUTE, INC.'s trademark registration success rate?
SOUTHWEST EYE INSTITUTE, INC. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.